Skip to main content

Table 1 Baseline Characteristics of Children with Graves’ Disease

From: Effects of glucocorticoid pulse therapy on thyroid function and thyroid antibodies in children with graves’ disease

Characteristic

The pulse group (N = 20)

The control group (N = 20)

P value

Gender [male(%)/female(%)]

6 (30.0)/14 (70.0)

4 (20.0)/16 (80.0)

0.465

Age (year)

7.7 ± 3.2

8.9 ± 4.0

0.303

Duration (year)

0.50 (0.18,1.00)

0.50 (0.27,1.00)

0.901

Palpitations(%)

8 (40.0)

10 (50.0)

0.525

Fatigue (%)

9 (45.0)

10 (50.0)

0.752

Irritability (%)

16 (80.0)

15 (75.0)

0.705

Increased appetite (%)

11 (55.0)

9 (45.0)

0.527

Weight loss (%)

3 (15.0)

4 (20.0)

0.677

Diarrhoea (%)

7 (35.0)

9 (45.0)

0.519

Increased perspiration (%)

11 (55.0)

12 (60.0)

0.749

Exophthalmos (mm)

17.85 ± 4.09

18.25 ± 4.36

0.767

Goiter grade 1 (%)

5 (25.0)

4 (20.0)

0.705

Goiter grade 2 (%)

15 (75.0)

16 (80.0)

0.705

Heart rate (bpm)

114 ± 18

115 ± 17

0.873

Systolic blood pressure (mmHg)

121 ± 12

124 ± 11

0.449

Diastolic blood pressure (mmHg)

71 ± 4

74 ± 5

0.063

TPOAb(+) (%)

17 (85.0)

17 (85.0)

1.000

TGAb(+) (%)

15 (75.0)

14 (70.0)

0.723

TRAb(+) (%)

20 (100.0)

19 (95.0)

0.311

  1. Data are presented as means±SD, median (interquartile range), or number (percentage)
  2. Abbreviations: TPOAb thyroid peroxidase antibodies, TGAb thyroglobulin antibodies, TRAb thyroid stimulating hormone receptor antibodies